Windlas Biotech informs about transcript of conference call

09 Nov 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that it attached Q2 FY22 Earnings Conference Call Transcript.

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

786.40 -16.15 (-2.01%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×